Skip to Content
Merck
CN
All Photos(1)

Documents

B4184

Sigma-Aldrich

Brij® L23 solution

30 % (w/v) in H2O

Sign Into View Organizational & Contract Pricing
All Photos(1)
Synonym(s):
Brij® 35 solution, C12E23, Polyoxyethylene (23) lauryl ether
CAS Number:
9002-92-0
MDL number:
MFCD00080891
UNSPSC Code:
12161900
PubChem Substance ID:
24891758
NACRES:
NA.25

biological source

synthetic

Quality Level

200

description

non-ionic

form

liquid

mol wt

~1198.0 g/mol

concentration

30 % (w/v) in H2O

aggregation number

40

CMC

91 μM

transition temp

cloud point ≥100 °C

solubility

water: soluble

density

1.024 g/mL

HLB

16.9

SMILES string

CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO

InChI

1S/C58H118O24/c1-2-3-4-5-6-7-8-9-10-11-13-60-15-17-62-19-21-64-23-25-66-27-29-68-31-33-70-35-37-72-39-41-74-43-45-76-47-49-78-51-53-80-55-57-82-58-56-81-54-52-79-50-48-77-46-44-75-42-40-73-38-36-71-34-32-69-30-28-67-26-24-65-22-20-63-18-16-61-14-12-59/h59H,2-58H2,1H3

InChI key

IEQAICDLOKRSRL-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Brij® L23, also known as Polyoxyethylene (23) lauryl ether, is an ethoxylated fatty alcohol derived from lauryl alcohol. It serves as a valuable non-ionic detergent widely utilized in biochemical studies. This versatile compound is particularly well-suited for protein solubilization and membrane protein isolation, making it a key component in various biochemical assays. Brij® L23′s non-ionic nature and unique properties also position it as an essential detergent for protein extraction and cell permeabilization, facilitating a broad spectrum of research in the same. Further, its use is instrumental in preserving the structural integrity and functionality of proteins, contributing significantly to studies involving proteins and their interactions in the area of biochemical research.

Application

Brij® L23 solution has been used:
  • as a supplement of De Man, Rogosa, Sharpe (MRS) broth for monitoring bacteriocin production by lactic acid bacteria(66)
  • as a component of developing buffer for the incubation of zymogram gel for metalloproteinase quantification(67)
  • as a component of activation buffer for recombinant human hepsin(68)

Biochem/physiol Actions

Brij® L23 solution is a surfactant and is used in the nanoparticle preparation by microemulsion method.

Features and Benefits

High-purity product ideal for biochemical research applications

Packaging

Some bottles may appear indented due to the packaging process. This does not affect product integrity or quality.

Preparation Note

In the event that material is in the gel phase at room temperature, the customer should heat the material to a temperature range of greater than 35°C and less than 60°C, and stir the solution for approximately 15 minutes before use.

Other Notes

For additional information on our range of Biochemicals, please complete this form.

Legal Information

Brij is a registered trademark of Croda International PLC

Pictograms

Exclamation markEnvironment
GHS07,GHS09

Signal Word

Warning

Hazard Statements

H315,H319,H411

Hazard Classifications

Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Reverse microemulsion synthesis of CeO2 nanopowder using polyoxyethylene (23) lauryl ether as a surfactant
Pournajaf R, et al.
Ceramics International, 40(6), 8687-8692 (2014)
Guillaume Morin et al.
Nutrients, 11(9) (2019-09-06)
Peroxides contaminating parenteral nutrition (PN) limit the use of methionine as a precursor of cysteine. Thus, PN causes a cysteine deficiency, characterized by low levels of glutathione, the main molecule used in peroxide detoxification, and limited growth in individuals receiving
Jun Koizumi et al.
AJR. American journal of roentgenology, 199(1), 200-207 (2012-06-27)
Balloon-occluded retrograde transvenous obliteration has been traditionally based on liquid sclerotherapy. However, overdose and systemic spillage of liquid sclerosant can cause severe complications, such as hemolysis, which lead to hemoglobinuria, allergy, acute respiratory distress syndrome, and other disorders. The purpose
Jacomina W van den Esschert et al.
Annals of surgery, 255(2), 311-318 (2012-01-14)
To compare the safety and hypertrophy response after portal vein embolization (PVE) using 2 absorbable and 3 permanent embolization materials. Portal vein embolization is used to increase future remnant liver volume preoperatively. Application of temporary, absorbable embolization materials could be
Otte Brosjö et al.
Acta orthopaedica, 84(5), 502-505 (2013-11-01)
Recent data suggest that percutaneous sclerotherapy is a safe alternative to surgery for treatment of aneurysmal bone cysts (ABCs). We present our experience of this method. We retrospectively analyzed data from 38 consecutive patients treated with repeated injections of polidocanol.
View All Related Papers

Articles

Enzymatic Assay of Cathepsin B

Cathepsin B is a lysosomal cysteine proteinase with broad specificity. This protocol uses Nα–CBZ–Arg–Arg–7–amido–4–methylcoumarin as the substrate for fluorometric detection of Cathepsin B activity.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service